Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Generics [UK] Limited, T/A Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL
Granisetron 1 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White to off-white tablet embossed “GS” on one side and plain on the reverse. |
Each tablet contains 1 mg granisetron (as hydrochloride).
Excipient with known effect: Each tablet contains 55.78 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Granisetron |
Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy. |
| List of Excipients |
|---|
|
Tablet core: Lactose Monohydrate Film coat: Titanium Dioxide (E171) |
PVC/PVDC aluminium foil opaque blisters in a cardboard carton and HDPE bottle with PE cap containing 1,2,4,5,6,7,10,14,20,28,30,50,90,100,150,200,250 and 500 tablets.
Not all pack sizes may be marketed.
Generics [UK] Limited, T/A Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL
PL 04569/0688
26/10/2005
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
